Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
about
Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trialRole of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysisGabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitisRisk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years.Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients.N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.Practice guidelines in acute pancreatitis.Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis.Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitisVisual characteristics of the papilla to estimate cannulation of the common bile duct - a pilot study.Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.Aggressive hydration with Lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial.Pharmacological approach to acute pancreatitis.Clinical practice guideline for post-ERCP pancreatitis.Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate.Impact of introduction of wire-guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography.Prevention of Post-ERCP Pancreatitis
P2860
Q24658599-B05CA6D0-26CC-48EA-88BD-3FA7E36E52EFQ28077968-4DC0CAB4-0D42-49DA-817D-876280230534Q33273455-F64CB89C-898D-48FC-A758-C487F6EC15CDQ33319646-29F44801-081B-47AE-B208-929C9CC590ABQ33673959-7F81371E-A787-4C2C-815D-554A87A72FDEQ33837450-8811E9A0-69EC-42A6-AC9B-FBC7FF5F7E21Q33866411-90EA9CFE-064A-4BB9-9DCC-9A3B7B5EE6C0Q34098709-8134B5FF-C5B3-46BA-B3F9-15DE64B2282AQ34390035-69B415E8-B515-47CB-8D03-66B96039FB4DQ34572933-81CC38B4-9EFA-4B01-BD02-33D308DF7F33Q35020441-9F155499-59F2-4A6C-897C-9F20590923ABQ35137859-1830EE90-FBD1-4DA0-8A8E-5D76428301A7Q35865775-2C3A1AF6-1D6F-4AFF-9802-271391DEC666Q35931242-4BDB73D8-A65E-42EA-8C9D-6018E42C0507Q35999845-D87CEF3F-ECF7-4AB3-A92C-6D28EFDF8A44Q36081203-46696D2B-5DAD-4861-BEFA-45189F4AA6B2Q36177978-7292F34C-BA26-4491-9C70-D431AEEB64F6Q36417258-952D8D6E-FF3E-4807-A7F2-A838C9C12454Q37169329-4B3D8481-5A1B-461A-8B07-F90B518C5454Q38707817-4EF5CCC7-2212-4B35-B76E-859C9E8F9CC0Q39977899-C0B7D786-D6F5-4D22-9C92-399916737096Q43516081-8C95A87B-319E-4900-8086-B13FD1117CABQ58701407-52E10AE3-8779-485E-9733-97DADDA90717
P2860
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@en
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@nl
type
label
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@en
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@nl
prefLabel
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@en
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@nl
P2093
P50
P1476
Prophylaxis of ERCP-related pa ...... ostatin and gabexate mesylate.
@en
P2093
Angelo Belmonte
Antonio Sabatino
Enrico Ciliberto
Francesco Perri
Fulvio Spirito
Giorgio Marenco
Giovambattista Forte
Luigi Solmi
Maria Rita Magnolia
Michele Silla
P304
P356
10.1016/S1542-3565(04)00295-2
P407
P577
2004-08-01T00:00:00Z